View drug registration information details.

Items	Registration information
ID	470
No	470
Brand Name	VEXLEV 250
Ingredients	LEVETIRACETAM USP 250 mg
Dosage Form	Film coated Tablets
Primary Packaging	Alu-Alu Blister
Storage	Store below 30°C. Protect from light.
Shelf Life	3 YEARS
Pack Size	BOX OF 3 X 10'S
Dispensing Category	PRESCRIPTION
ATC Classification
Pharmaceutical Class	Antiepileptic
Indications	Monotherapy of focal seizures with or without secondary generalisation  Adjunctive therapy of focal seizures with or without secondary generalisation  Adjunctive therapy of myoclonic seizures and tonic-clonic seizures
Contraindications	Levetiracetam tablets are contraindicated in patients with a hypersensitivity to levetiracetam. Reactions have included anaphylaxis and angioedema
Side Effects	anxiety, appetite decreased, asthenia, behaviour abnormal, cough, depression, diarrhoea, dizziness, drowsiness, gastrointestinal discomfort, headache, increased risk of infection, somnia, mood altered, movement disorders, nausea, skin reactions, vertigo, vomiting, alopecia, concentration impaired, confusion, hallucination, leucopenia, muscle weakness, myalgia,paraesthesia, psychotic disorder, suicidal tendencies, thrombocytopenia, vision disorders, weight changes
Unit Price
EDL	No
Description	A White colored, round shaped, biconvex, film IH coated tablet, plain on both side.
Note
License Owner	VE PRODUCTS (LAO) CO.,LTD
Manufacturer	4Care Lifescience Pvt. Ltd.
Country	INDIA
Import Registration No	G/25/2400
Import Registration Date
Activity	CERTIFICATE RELEASED
Applied Date	2024-10-15
FDD Registration No	12 I 5841/24
FDD Registration Date	2024-12-30
Expiry Date	2029-12-29

Back to drug list